AI product management · Industry brief

Aethryx, a Singapore-headquartered AI governance startup led by Dr. Brindha Jeyaraman, won the 2026 Global Recognition Award for Startup of the Year for its runtime AI governance platform that enforces policies, monitors AI behavior in live production environments, and supports compliance in regulated enterprises. The company addresses a structural gap in enterprise AI governance as global spending on AI governance and risk management is projected to exceed $10 billion by 2027, with the platform featuring dynamic risk tiering, policy-to-control enforcement, and decision traceability aligned with regulatory frameworks including the EU AI Act and MAS FEAT. Aethryx is currently in discussions with several enterprise organizations for pilot engagements expected to demonstrate measurable reductions in manual compliance effort and improved audit readiness for regulated financial environments.

FDA cleared UpDoc's type 2 diabetes management software on December 23, 2025, marking the first Software as a Medical Device (SaMD) approval for a patient-facing large language model application. The clearance establishes a regulatory pathway for clinical AI developers, though future approvals will depend on each product's specific intended functions, safety and efficacy. Organizations developing clinical AI must address comprehensive compliance requirements including HIPAA, data privacy, data governance, human-in-the-loop oversight, practice-of-medicine regulations, and post-market surveillance monitoring. Clinical AI is expected to function as a clinician support tool rather than make independent diagnostic decisions due to regulatory and state law requirements (McGuireWoods, July 6, 2026).

Bylaw (S2026, 3 employees, San Francisco) is building an AI guardrail system that validates data before AI agents take action on critical systems. The company blocks or escalates agent actions when evidence is wrong, outdated, or conflicts across sources—addressing a core failure mode in agent deployment where tools are called without verifying underlying facts. Founders previously worked at Meta, Optiver, and BitGo, where decisions on unverified data had serious consequences. Cardamon (W2025, 2 employees, London) is automating regulatory compliance for financial firms. The platform ingests regulations, determines applicability to each firm, and maps requirements to obligations and product specs in minutes rather than weeks—solving a bottleneck where compliance review was taking as long as product development itself. The founders previously led product at Revolut and experienced this friction firsthand.

India's PE-VC investments declined to $6.45 billion in Q2 2026, representing a 3% year-on-year drop and 42% quarterly decline, with capital becoming more selective and concentrated in mega deals. An Oxford Economics report projects that restrictive digital regulations could reduce annual venture capital investment by 25% by 2035, potentially resulting in over 2,000 fewer startups created annually. Policy predictability around data governance, compliance, competition, artificial intelligence, and platform accountability has emerged as a critical factor influencing investment decisions, with balanced regulatory frameworks essential to maintaining founder and investor confidence for long-term innovation planning.